Showing results (121-130 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 14, 2020
Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast CancerStephanie L Greville-Heygate, Tom Maishman, William J Tapper, et al.
JCO Precision Oncology|September 14, 2020
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian CancerYing L Liu, Pier Selenica, Qin Zhou, et al.
JCO Precision Oncology|September 14, 2020
Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in NeuroblastomaLieke M J van Zogchel, Esther M van Wezel, Jalenka van Wijk, et al.
JCO Precision Oncology|September 14, 2020
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast CancersTess O'Meara, Michal Marczyk, Tao Qing, et al.
JCO Precision Oncology|September 14, 2020
Opportunities and Challenges for Analyzing Cancer Data at the Inter- and Intra-Institutional LevelsJulie Wu, Jordan Bryan, Samuel M Rubinstein, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
JCO Precision Oncology|December 4, 2018
Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic AdenocarcinomaRobert J Torphy, Zhen Wang, Aisha True-Yasaki, et al.
JCO Precision Oncology|January 8, 2019
Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical TrialTara A Russell, Mark A Eckardt, Takashi Murakami, et al.
JCO Precision Oncology|December 7, 2020
Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast CancerKomal L Jhaveri, Carlos H Dos Anjos, Tony Taldone, et al.
JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Pageof 140